2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 IN VITRO DIAGNOSTIC DEVICES MARKET
4.2.1.1 Drivers
4.2.1.1.1 Gradual shift from centralized testing to point-of-care testing
4.2.1.1.2 Growing awareness of early disease diagnosis across emerging countries
4.2.1.2 Restraints
4.2.1.2.1 Reimbursement pressure and test-price controls
4.2.1.3 Opportunities
4.2.1.3.1 Expansion of companion diagnostics (CDx) and oncology testing
4.2.1.4 Challenges
4.2.1.4.1 Operational barriers and data privacy and cybersecurity risks
4.2.2 CARDIOVASCULAR DEVICES MARKET
4.2.2.1 Drivers
4.2.2.1.1 Rising prevalence of cardiovascular diseases
4.2.2.2 Restraints
4.2.2.2.1 Stringent regulatory guidelines for product approval
4.2.2.3 Opportunities
4.2.2.3.1 Growing healthcare needs and improving medical infrastructure in emerging countries
4.2.2.4 Challenges
4.2.2.4.1 Product recalls and device-related safety events
4.2.3 IMAGING DEVICES MARKET
4.2.3.1 Drivers
4.2.3.1.1 Increasing funds, investments, and grants by public-private investors
4.2.3.2 Restraints
4.2.3.2.1 High cost of diagnostic imaging systems
4.2.3.3 Opportunities
4.2.3.3.1 Growing adoption of artificial intelligence (AI) and advanced analytics
4.2.3.4 Challenges
4.2.3.4.1 Increasing adoption of refurbished diagnostic imaging systems
4.2.4 ORTHOPEDIC DEVICES MARKET
4.2.4.1 Drivers
4.2.4.1.1 Rising prevalence of orthopedic diseases
4.2.4.2 Restraints
4.2.4.2.1 Risks and complications associated with orthopedic surgical procedures
4.2.4.2.2 High cost of orthopedic devices and surgical procedures
4.2.4.3 Opportunities
4.2.4.3.1 Increasing adoption of robotics and 3D printing in orthopedics
4.2.4.4 Challenges
4.2.4.4.1 Shortage of orthopedic surgeons
4.2.5 OPHTHALMOLOGY DEVICES MARKET
4.2.5.1 Drivers
4.2.5.1.1 Rising prevalence of eye disorders
4.2.5.2 Restraints
4.2.5.2.1 High cost & potential risks associated with eye surgery
4.2.5.3 Opportunities
4.2.5.3.1 Growing adoption of minimally invasive ophthalmic surgical procedures
4.2.5.4 Challenges
4.2.5.4.1 Low accessibility to eye care services in emerging and low-income countries
4.2.6 ENDOSCOPY DEVICES MARKET
4.2.6.1 Drivers
4.2.6.1.1 Rising investments, funding, and grants for endoscopy procedures
4.2.6.1.2 Increasing incidence of inflammatory bowel disease (IBD) and colorectal cancer
4.2.6.2 Restraints
4.2.6.2.1 High overhead cost and procedural risks associated with endoscopy
4.2.6.3 Opportunities
4.2.6.3.1 Rapidly developing healthcare sector in emerging economies
4.2.6.4 Challenges
4.2.6.4.1 Increasing number of product recalls
4.2.6.5 Lack of proper sterilization and reprocessing
4.2.7 DIABETES CARE DEVICES MARKET
4.2.7.1 Drivers
4.2.7.1.1 Increasing prevalence of diabetes
4.2.7.2 Restraints
4.2.7.2.1 High cost of advanced diabetes care devices
4.2.7.3 Opportunities
4.2.7.3.1 Increasing adoption of advanced implantable continuous glucose monitoring (CGM) devices
4.2.7.4 Challenges
4.2.7.4.1 High costs and socioeconomic disparities
4.2.8 WOUND CARE DEVICES MARKET
4.2.8.1 Drivers
4.2.8.1.1 Rising incidents of traumatic injuries and burn cases
4.2.8.2 Restraints
4.2.8.2.1 Risks associated with advanced wound care
4.2.8.3 Opportunities
4.2.8.3.1 Growth potential in emerging economies
4.2.8.4 Challenges
4.2.8.4.1 Shortage of trained professionals and limited access to wound care devices
4.2.9 KIDNEY/DIALYSIS DEVICES MARKET
4.2.9.1 Drivers
4.2.9.1.1 Rising prevalence of chronic kidney disease (CKD)
4.2.9.2 Restraints
4.2.9.2.1 Risks, complications, and high procedural costs associated with dialysis treatments
4.2.9.3 Opportunities
4.2.9.3.1 Increasing number of dialysis centers in emerging economies
4.2.9.4 Challenges
4.2.9.4.1 Increasing number of product recalls and growing preference for renal transplantation
4.2.10 RESPIRATORY CARE DEVICES MARKET
4.2.10.1 Drivers
4.2.10.1.1 Rising prevalence of chronic respiratory disease
4.2.10.2 Restraints
4.2.10.2.1 Unfavorable reimbursement scenario
4.2.10.3 Opportunities
4.2.10.3.1 High growth in developing countries across Asia Pacific and Latin America
4.2.10.4 Challenges
4.2.10.4.1 Harmful effects of certain devices on neonates
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN MEDICAL DEVICES MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY (MIS) INDUSTRY
5.2.4 TRENDS IN SURGICAL ROBOTS INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY KEY PLAYER (2023-2025)
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY REGION(2023-2025)
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 9018)
5.7.2 EXPORT DATA (HS CODE 9018)
5.8 KEY CONFERENCES & EVENTS, 2026-2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 IMPACT OF 2025 US TARIFFS ON MEDICAL DEVICES MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRIES/REGIONS
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 END-USE INDUSTRY IMPACT
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 ROBOTIC-ASSISTED & COMPUTER-ASSISTED INTERVENTIONS
6.1.2 POINT-OF-CARE (POC) & MINIATURIZED DIAGNOSTICS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 DIGITAL INTERNET OF MEDICAL THINGS (IOMT) & CLOUD CONNECTIVITY
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.3.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
6.3.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4 PATENT ANALYSIS
6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
6.5 FUTURE APPLICATIONS
6.6 IMPACT OF AI/GEN AI ON MEDICAL DEVICES MARKET
6.6.1 TOP USE CASES & MARKET POTENTIAL
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL DEVICES MARKET
6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICALDEVICES MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 CARBON IMPACT & ECO-APPLICATIONS OF MEDICAL DEVICES MARKET
7.2.1.1 Carbon impact reduction
7.2.1.2 Eco-applications
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
7.5 REIMBURSEMENT ANALYSIS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 MEDICAL DEVICES MARKET, BY TYPE
9.1 INTRODUCTION
9.2 IN VITRO DIAGNOSTIC DEVICES
9.2.1 WIDESPREAD DIAGNOSTIC TESTING TO DRIVE DEMAND FOR IN VITRO DIAGNOSTIC DEVICES
9.3 CARDIOVASCULAR DEVICES
9.3.1 RISING CARDIOVASCULAR DISEASE BURDEN TO DRIVE DEMAND FOR CARDIOVASCULAR DEVICES
9.4 WOUND CARE DEVICES
9.4.1 RISING PREVALENCE OF CHRONIC WOUNDS AND ADVANCED WOUND MANAGEMENT TO DRIVE WOUND CARE DEVICE ADOPTION
9.5 RESPIRATORY CARE DEVICES
9.5.1 SHIFT TOWARD HOME-BASED RESPIRATORY MANAGEMENT AND NONINVASIVE THERAPIES TO DRIVE DEVICE ADOPTION
9.6 ORTHOPEDIC DEVICES
9.6.1 GROWING MUSCULOSKELETAL DISEASE BURDEN AND ADVANCES IN RECONSTRUCTIVE SURGERY TO SUPPORT MARKET GROWTH
9.7 KIDNEY/DIALYSIS DEVICES
9.7.1 RISING BURDEN OF CHRONIC KIDNEY DISEASE AND EXPANDING RENAL REPLACEMENT THERAPIES TO BOOST GROWTH
9.8 DIABETES CARE DEVICES
9.8.1 RISING DIABETES PREVALENCE AND ADVANCES IN CONTINUOUS GLUCOSE MONITORING TO FUEL GROWTH
9.9 ENDOSCOPY DEVICES
9.9.1 GROWING DEMAND FOR MINIMALLY INVASIVE DIAGNOSIS AND THERAPY TO CONTRIBUTE TO MARKET GROWTH
9.10 OPHTHALMOLOGY DEVICES
9.10.1 RISING GLOBAL BURDEN OF VISION IMPAIRMENT TO BOOST MARKET GROWTH
9.11 IMAGING DEVICES
9.11.1 GROWING DEMAND FOR ADVANCED DIAGNOSTIC IMAGING O FUEL GROWTH
9.12 OTHER MEDICAL DEVICES
10 MEDICAL DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to hold major share in North American medical devices market
10.2.3 CANADA
10.2.3.1 Growing chronic disease burden and aging population to support Canada’s market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Germany's leadership in medtech manufacturing, hospital modernization, and aging population to support market expansion
10.3.3 UK
10.3.3.1 NHS diagnostic modernization and medtech innovation to accelerate market growth
10.3.4 FRANCE
10.3.4.1 France's emphasis on early diagnosis and specialized care to drive medical device demand
10.3.5 ITALY
10.3.5.1 Hospital technology modernization and expanding surgical care to drive medical device demand
10.3.6 SPAIN
10.3.6.1 Digital transformation of national health system to accelerate medical device adoption
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Healthcare capacity expansion to drive medical device demand in China
10.4.3 JAPAN
10.4.3.1 Healthy aging policies and advanced healthcare delivery to drive market growth
10.4.4 INDIA
10.4.4.1 Expanding specialty healthcare access to drive medical device demand
10.4.5 AUSTRALIA
10.4.5.1 Expanding access to specialist healthcare services to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Biohealth innovation and AI-enabled healthcare to drive adoption
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Strengthening domestic healthcare innovation and medical device production to boost market
10.5.3 MEXICO
10.5.3.1 Medical technology manufacturing expansion to support growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Healthcare transformation programs and smart hospital initiatives to drive medical device demand
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL DEVICES MARKET
11.3 REVENUE ANALYSIS, 2021-2025
11.4 MARKET SHARE ANALYSIS, 2025
11.4.1 GLOBAL IN VITRO DIAGNOSTIC DEVICES MARKET SHARE ANALYSIS, 2025
11.4.2 GLOBAL CARDIOVASCULAR DEVICES MARKET SHARE ANALYSIS, 2025
11.4.3 GLOBAL ORTHOPEDIC DEVICES MARKET SHARE ANALYSIS, 2025
11.4.4 GLOBAL DIABETES CARE DEVICES MARKET SHARE ANALYSIS, 2025
11.4.5 GLOBAL ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2025
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
11.9.2 DEALS
11.9.3 EXPANSION
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MEDTRONIC PLC
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.4 Analyst's view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 JOHNSON & JOHNSON
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches & approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 Analyst's view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 ABBOTT
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches & approvals
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.4 KONINKLIJKE PHILIPS N.V.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.5 SIEMENS HEALTHINEERS AG
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches & approvals
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.6 STRYKER CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 B. BRAUN SE
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.7.3.2 Expansions
12.1.7.4 Analyst's view
12.1.7.4.1 Right to win
12.1.7.4.2 Strategic choices
12.1.7.4.3 Weaknesses & competitive threats
12.1.8 SMITH & NEPHEW
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.9 BOSTON SCIENTIFIC CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product approvals
12.1.9.3.2 Deals
12.1.10 F. HOFFMANN-LA ROCHE LTD.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches & approvals
12.1.10.3.2 Deals
12.2 OTHER PLAYERS
12.2.1 BECTON, DICKINSON AND COMPANY
12.2.2 BAXTER INTERNATIONAL, INC.
12.2.3 ZIMMER BIOMET HOLDINGS, INC.
12.2.4 OLYMPUS CORPORATION
12.2.5 TERUMO CORPORATION
12.2.6 FUJIFILM CORPORATION
12.2.7 DANAHER CORPORATION
12.2.8 FRESENIUS SE & CO. KGAA
12.2.9 TELEFLEX INCORPORATED
12.2.10 GE HEALTHCARE TECHNOLOGIES INC.
12.2.11 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
12.2.12 DEXCOM, INC.
12.2.13 THERMO FISHER SCIENTIFIC INC.
12.2.14 ALCON INC.
12.2.15 NIPRO CORPORATION
13 RESEARCH METHODOLOGY
13.1 RESEARCH DATA
13.1.1 SECONDARY DATA
13.1.1.1 Key data from secondary sources
13.1.2 PRIMARY DATA
13.1.2.1 Key data from primary sources
13.1.2.2 Key industry insights
13.2 MARKET SIZE ESTIMATION
13.3 MARKET BREAKDOWN & DATA TRIANGULATION
13.4 MARKET RANKING ANALYSIS
13.5 STUDY ASSUMPTIONS
13.6 RESEARCH LIMITATIONS
13.6.1 METHODOLOGY-RELATED LIMITATIONS
13.6.2 SCOPE-RELATED LIMITATIONS
13.7 RISK ASSESSMENT
LIST OF TABLES
TABLE 1 MEDICAL DEVICES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 LIST OF INVESTMENT FOR IMAGING DEVICES
TABLE 4 LIST OF RECALLS BY KEY PLAYERS
TABLE 5 MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030
TABLE 7 AVERAGE SELLING PRICE TREND OF MEDICAL DEVICES, BY KEY PLAYER,2023-2025 (USD)
TABLE 8 AVERAGE PRICING TREND OF MEDICAL DEVICES, BY REGION, 2023-2025 (USD)
TABLE 9 IMPORT DATA FOR MEDICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
TABLE 10 EXPORT DATA FOR MEDICAL DEVICES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
TABLE 11 MEDICAL DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026-2027)
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR MEDICAL DEVICES
TABLE 14 AI-ENABLED DIAGNOSTICS, DIGITAL HEALTH, AND PRECISION MEDICINE
TABLE 15 CONNECTED MEDICAL DEVICES, REMOTE MONITORING, ANDSMART HEALTHCARE ECOSYSTEMS
TABLE 16 TOP USE CASES & MARKET POTENTIAL
TABLE 17 MEDICAL DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
TABLE 18 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 GLOBAL STANDARDS IN MEDICAL DEVICES MARKET
TABLE 25 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL DEVICES MARKET
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE MEDICAL DEVICES
TABLE 28 MEDICAL DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 29 MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 30 IN VITRO DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 31 CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 32 WOUND CARE DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 33 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 34 ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 35 KIDNEY/DIALYSIS DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 36 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 37 ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 38 OPHTHALMOLOGY DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 39 IMAGING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 40 OTHER MEDICAL DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 41 MEDICAL DEVICES MARKET, BY REGION, 2024-2031 (USD BILLION)
TABLE 42 NORTH AMERICA: MEDICAL DEVICES MARKET, BY COUNTRY,2024-2031 (USD BILLION)
TABLE 43 NORTH AMERICA: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 44 US: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 45 CANADA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 46 EUROPE: MEDICAL DEVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
TABLE 47 EUROPE: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 48 GERMANY: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 49 UK: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 50 FRANCE: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 51 ITALY: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 52 SPAIN: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 53 REST OF EUROPE: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 54 ASIA PACIFIC: MEDICAL DEVICES MARKET, BY COUNTRY,2024-2031 (USD BILLION)
TABLE 55 ASIA PACIFIC: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 56 CHINA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 57 JAPAN: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 58 INDIA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 59 AUSTRALIA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 60 SOUTH KOREA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 61 REST OF ASIA PACIFIC: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 62 LATIN AMERICA: MEDICAL DEVICES MARKET, BY COUNTRY,2024-2031 (USD BILLION)
TABLE 63 LATIN AMERICA: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 64 BRAZIL: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 65 MEXICO: MEDICAL DEVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
TABLE 66 REST OF LATIN AMERICA: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 67 MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY REGION,2024-2031 (USD BILLION)
TABLE 68 MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 69 GCC COUNTRIES: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 70 REST OF MIDDLE EAST & AFRICA: MEDICAL DEVICES MARKET, BY TYPE,2024-2031 (USD BILLION)
TABLE 71 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MEDICALDEVICES MARKET
TABLE 72 MEDICAL DEVICES MARKET: REGION FOOTPRINT
TABLE 73 MEDICAL DEVICES MARKET: TYPE FOOTPRINT
TABLE 74 MEDICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 75 MEDICAL DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 76 MEDICAL DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JUNE 2026
TABLE 77 MEDICAL DEVICES MARKET: DEALS, JANUARY 2022-JUNE 2026
TABLE 78 MEDICAL DEVICES MARKET: EXPANSION, JANUARY 2022-JUNE 2026
TABLE 79 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 80 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 81 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS,JANUARY 2021-JUNE 2026
TABLE 82 JOHNSON & JOHNSON: COMPANY OVERVIEW
TABLE 83 JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 84 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS,JANUARY 2021-JUNE 2026
TABLE 85 JOHNSON & JOHNSON: DEALS, JANUARY 2021-JUNE 2026
TABLE 86 JOHNSON & JOHNSON: EXPANSIONS, JANUARY 2021-JUNE 2026
TABLE 87 ABBOTT: COMPANY OVERVIEW
TABLE 88 ABBOTT: PRODUCTS OFFERED
TABLE 89 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JUNE 2026
TABLE 90 ABBOTT: DEALS, JANUARY 2022-JUNE 2026
TABLE 91 ABBOTT: EXPANSIONS, JANUARY 2022-JUNE 2026
TABLE 92 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 93 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 94 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2026
TABLE 95 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-JUNE 2026
TABLE 96 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022-JUNE 2026
TABLE 97 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 98 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 99 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS,JANUARY 2022-JUNE 2026
TABLE 100 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-JUNE 2026
TABLE 101 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021-JUNE 2026
TABLE 102 STRYKER CORPORATION: COMPANY OVERVIEW
TABLE 103 STRYKER CORPORATION: PRODUCTS OFFERED
TABLE 104 STRYKER CORPORATION: DEALS, JANUARY 2021-JUNE 2026
TABLE 105 B. BRAUN SE: COMPANY OVERVIEW
TABLE 106 B. BRAUN SE: PRODUCTS OFFERED
TABLE 107 B. BRAUN SE: DEALS, JANUARY 2021-JUNE 2026
TABLE 108 B. BRAUN SE: EXPANSIONS, JANUARY 2021-JUNE 2026
TABLE 109 SMITH & NEPHEW: COMPANY OVERVIEW
TABLE 110 SMITH & NEPHEW: PRODUCTS OFFERED
TABLE 111 SMITH & NEPHEW: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2026
TABLE 112 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 113 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 114 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021-JUNE 2026
TABLE 115 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022-JUNE 2026
TABLE 116 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 117 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 118 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS,JANUARY 2022-JUNE 2026
TABLE 119 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022-JUNE 2026
TABLE 120 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
TABLE 121 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
TABLE 122 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS OVERVIEW
TABLE 123 OLYMPUS CORPORATION: BUSINESS OVERVIEW
TABLE 124 TERUMO CORPORATION: BUSINESS OVERVIEW
TABLE 125 FUJIFILM CORPORATION: BUSINESS OVERVIEW
TABLE 126 DANAHER CORPORATION: BUSINESS OVERVIEW
TABLE 127 FRESENIUS SE & CO. KGAA: BUSINESS OVERVIEW
TABLE 128 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
TABLE 129 GE HEALTHCARE TECHNOLOGIES INC.: BUSINESS OVERVIEW
TABLE 130 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
TABLE 131 DEXCOM, INC.: BUSINESS OVERVIEW
TABLE 132 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
TABLE 133 ALCON INC.: BUSINESS OVERVIEW
TABLE 134 NIPRO CORPORATION: BUSINESS OVERVIEW
TABLE 135 MEDICAL DEVICES MARKET: STUDY ASSUMPTIONS
TABLE 136 MEDICAL DEVICES MARKET: RISK ASSESSMENT ANALYSIS
LIST OF FIGURES
FIGURE 1 MEDICAL DEVICES MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 MEDICAL DEVICES MARKET, 2026 - 2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL DEVICES MARKET
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL DEVICES MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL DEVICES MARKET, 2025
FIGURE 7 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2025
FIGURE 8 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
FIGURE 9 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 10 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 11 IN VITRO DIAGNOSTIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 CARDIOVASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 IMAGING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 14 ORTHOPEDIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 15 OPHTHALMOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 ENDOSCOPY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 17 DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 18 WOUND CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 19 KIDNEY/DIALYSIS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 20 RESPIRATORY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 21 MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 MEDICAL DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 23 MEDICAL DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 24 MEDICAL DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 26 MEDICAL DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
FIGURE 27 NUMBER OF PATENTS PUBLISHED (JANUARY 2015-JUNE 2026)
FIGURE 28 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES(JANUARY 2015-JUNE 2026)
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
FIGURE 30 KEY BUYING CRITERIA FOR MEDICAL DEVICES
FIGURE 31 MEDICAL DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 32 NORTH AMERICA: MEDICAL DEVICES MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: MEDICAL DEVICES MARKET SNAPSHOT
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICES MARKET (2021-2025)
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IN VITRO DIAGNOSTIC DEVICES MARKET (2025)
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CARDIOVASCULAR DEVICES MARKET (2025)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC DEVICES MARKET (2025)
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIABETES CARE DEVICES MARKET (2025)
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENDOSCOPY DEVICES MARKET (2025)
FIGURE 40 MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 41 MEDICAL DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 42 MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX(STARTUPS/SMES), 2025
FIGURE 43 EV/EBITDA OF KEY VENDORS
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCKBETA OF KEY VENDORS
FIGURE 45 MEDICAL DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2025)
FIGURE 47 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025)
FIGURE 48 ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 50 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
FIGURE 51 STRYKER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2025)
FIGURE 53 SMITH & NEPHEW: COMPANY SNAPSHOT (2025)
FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 56 RESEARCH DESIGN
FIGURE 57 PRIMARY SOURCES
FIGURE 58 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 59 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 60 TOP-DOWN APPROACH
FIGURE 61 BOTTOM-UP APPROACH
FIGURE 62 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026-2031)
FIGURE 63 MEDICAL DEVICES MARKET: CAGR PROJECTIONS
FIGURE 64 DATA TRIANGULATION METHODOLOGY
